Prognostic Significance of Plasma Folate and Cobalamin Concentrations in Non-Muscle-Invasive Bladder Cancer: A Prospective Cohort Study

References

• Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71(1):96–108. doi:10.1016/j.eururo.2016.06.010.
   PubMed Web of Science ®Google Scholar
• Ma G, Yang X, Liang Y, Wang L, Li D, Chen Y, et al. Precision medicine and bladder cancer heterogeneity. Bull Cancer. 2018;105(10):925–931. doi:10.1016/j.bulcan.2018.07.015.
   PubMed Web of Science ®Google Scholar
• Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009;374(9685):239–249. doi:10.1016/S0140-6736(09)60491-8.
   PubMed Web of Science ®Google Scholar
• Svatek RS, Hollenbeck BK, Holmäng S, Lee R, Kim SP, Stenzl A, et al. The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol. 2014;66(2):253–262. doi:10.1016/j.eururo.2014.01.006.
   PubMed Web of Science ®Google Scholar
• Crott JW, Liu Z, Keyes MK, Choi SW, Jang H, Moyer MP, et al. Moderate folate depletion modulates the expression of selected genes involved in cell cycle, intracellular signaling and folate uptake in human colonic epithelial cell lines. J Nutr Biochem. 2008;19(5):328–335. doi:10.1016/j.jnutbio.2007.05.003.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Li Q, Chen Y, Huang X, Yang IH, Cao L, et al. Homocysteine-impaired angiogenesis is associated with VEGF/VEGFR inhibition. Front Biosci (Elite Ed). 2012;4:2525–2535. doi:10.2741/e563.
   PubMedGoogle Scholar
• Strickland KC, Krupenko NI, Krupenko SA. Molecular mechanisms underlying the potentially adverse effects of folate. Clin Chem Lab Med. 2013;51(3):607–616. doi:10.1515/cclm-2012-0561.
   PubMed Web of Science ®Google Scholar
• Das UN. Nutritional factors in the prevention and management of coronary artery disease and heart failure. Nutrition. 2015;31(2):283–291. doi:10.1016/j.nut.2014.08.011.
   PubMed Web of Science ®Google Scholar
• Saghiri MA, Asatourian A, Ershadifar S, Moghadam MM, Sheibani N. Vitamins and regulation of angiogenesis: (A, B1, B2, B3, B6, B9, B12, C, D, E, K). J Funct Foods. 2017;38:180–196. doi:10.1016/j.jff.2017.09.005.
   Web of Science ®Google Scholar
• Ebbing M, Bønaa KH, Nygård O, Arnesen E, Ueland PM, Nordrehaug JE, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA. 2009;302(19):2119–2126. doi:10.1001/jama.2009.1622.
   PubMed Web of Science ®Google Scholar
• Chen P, Li C, Li X, Li J, Chu R, Wang H. Higher dietary folate intake reduces the breast cancer risk: a systematic review and meta-analysis. Br J Cancer. 2014;110(9):2327–2338. doi:10.1038/bjc.2014.155.
   PubMed Web of Science ®Google Scholar
• Matejcic M, de Batlle J, Ricci C, Biessy C, Perrier F, Huybrechts I, et al. Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort. Int J Cancer. 2017;140(6):1246–1259. doi:10.1002/ijc.30536.
   PubMed Web of Science ®Google Scholar
• Ma JL, Zhao Y, Guo CY, Hu HT, Zheng L, Zhao EJ, et al. Dietary vitamin B intake and the risk of esophageal cancer: a meta-analysis. Cancer Manag Res. 2018;10:5395–5410. doi:10.2147/CMAR.S168413.
   PubMed Web of Science ®Google Scholar
• Oliai Araghi S, Kiefte-de Jong JC, van Dijk SC, Swart KMA, van Laarhoven HW, van Schoor NM, et al. Folic acid and vitamin B12 supplementation and the risk of cancer: long-term follow-up of the B vitamins for the prevention of osteoporotic fractures (B-PROOF) trial. Cancer Epidemiol Biomarkers Prev. 2019;28(2):275–282. doi:10.1158/1055-9965.EPI-17-1198.
   PubMed Web of Science ®Google Scholar
• Fanidi A, Carreras-Torres R, Larose TL, Yuan JM, Stevens VL, Weinstein SJ, LC3 consortium and the TRICL consortium, et al. consortium and the TRICL consortium. Is high vitamin B12 status a cause of lung cancer? Int J Cancer. 2019;145(6):1499–1503. doi:10.1002/ijc.32033.
   PubMed Web of Science ®Google Scholar
• He H, Shui B. Folate intake and risk of bladder cancer: a meta-analysis of epidemiological studies. Int J Food Sci Nutr. 2014;65(3):286–292. doi:10.3109/09637486.2013.866641.
   PubMed Web of Science ®Google Scholar
• Ben Fradj MK, Mrad Dali K, Kallel A, Bibi M, Ben Rhouma S, Sanhaji H, et al. Interaction effects of plasma vitamins A, E, D, B9, and B12 and tobacco exposure in urothelial bladder cancer: a multifactor dimensionality reduction analysis. Nutr Cancer. 2019;71(8):1382–1389. doi:10.1080/01635581.2019.1609531.
   PubMed Web of Science ®Google Scholar
• Bassett JK, Brinkman MT, Dugué PA, Ueland PM, Midttun Ø, Ulvik A, et al. Circulating concentrations of B group vitamins and urothelial cell carcinoma. Int J Cancer. 2019;144(8):1909–1917. doi:10.1002/ijc.31927.
   PubMed Web of Science ®Google Scholar
• Dugué PA, Brinkman MT, Hodge AM, Bassett JK, Bolton D, Longano A, et al. Dietary intake of nutrients involved in one-carbon metabolism and risk of urothelial cell carcinoma: a prospective cohort study. Int J Cancer. 2018;143(2):298–306. doi:10.1002/ijc.31319.
   PubMed Web of Science ®Google Scholar
• Arendt JF, Farkas DK, Pedersen L, Nexo E, Sørensen HT. Elevated plasma vitamin B12 levels and cancer prognosis: a population-based cohort study. Cancer Epidemiol. 2016;40:158–165. doi:10.1016/j.canep.2015.12.007.
   PubMed Web of Science ®Google Scholar
• Tu H, Dinney CP, Ye Y, Grossman HB, Lerner SP, Wu X. Is folic acid safe for non-muscle-invasive bladder cancer patients? An evidence-based cohort study. Am J Clin Nutr. 2018;107(2):208–216. doi:10.1093/ajcn/nqx019.
   PubMed Web of Science ®Google Scholar
• Greene FL, Page DL, Flemming ID, Fritz A, Balch CM, Haller DG, et al. American joint committee on cancer staging manual. New York: Springer; 2002.
   Google Scholar
• Mostofi FK, Sobin LH, Torloni H. Histologic typing of urinary bladders. Geneva: World Health Organisation; 1973.
   Google Scholar
• Ohrvik VE, Witthoft CM. Human folate bioavailability. Nutrients. 2011;3(4):475–490. doi:10.3390/nu3040475.
   PubMed Web of Science ®Google Scholar
• Kouidhi S, Rouissi K, Khedhiri S, Ouerhani S, Cherif M, Benammar-Elgaaied A. Benammar-Elgaaied A. MTHFR gene polymorphisms and bladder cancer susceptibility: a meta-analysis including race, smoking status and tumour stage. Asian Pac J Cancer Prev. 2011;12(9):2227–2232.
   PubMedGoogle Scholar
• Lu C, Xie H, Wang F, Shen H, Wang J. Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma. BMC Cancer. 2011;11:91. doi:10.1186/1471-2407-11-91.
   PubMed Web of Science ®Google Scholar
• Zhang L, Liu W, Hao Q, Bao L, Wang K. Folate intake and methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers for ovarian cancer risk. Int J Mol Sci. 2012;13(4):4009–4020. doi:10.3390/ijms13044009.
   PubMed Web of Science ®Google Scholar
• Moreira DM, Banez LL, Presti Jr JC, Aronson WJ, Terris MK, Kane CJ, et al. High serum folate is associated with reduced biochemical recurrence after radical prostatectomy: results from the SEARCH Database. Int Braz J Urol. 2013;39(3):312–318. doi:10.1590/S1677-5538.IBJU.2013.03.03.
   PubMed Web of Science ®Google Scholar
• Fang AP, Liu ZY, Liao GC, Chen PY, Wang XY, Zhang DM, et al. Serum folate concentrations at diagnosis are associated with hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort study. Br J Nutr. 2019;121(12):1376–1388. doi:10.1017/S0007114519000734.
   PubMed Web of Science ®Google Scholar
• Dixon SC, Ibiebele TI, Protani MM, Beesley J, deFazio A, Crandon AJ, Australian Ovarian Cancer Study Group, et al. Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival. Gynecol Oncol. 2014;132(3):566–572. doi:10.1016/j.ygyno.2013.12.025.
   PubMed Web of Science ®Google Scholar
• Lin CY, Kuo CS, Lu CL, Wu MY, Huang RF. Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma. Nutr Cancer. 2010;62(2):190–197. doi:10.1080/01635580903305334.
   PubMed Web of Science ®Google Scholar
• Geissbühler P, Mermillod B, Rapin CH. Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years. J Pain Symptom Manage. 2000;20(2):93–103. doi:10.1016/S0885-3924(00)00169-X.
   PubMed Web of Science ®Google Scholar
• Tomaszewski JJ, Cummings JL, Parwani AV, Dhir R, Mason JB, Nelson JB, et al. Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate. Prostate. 2011;71(12):1287–1293. doi:10.1002/pros.21346.
   PubMed Web of Science ®Google Scholar
• Wolpin BM, Wolpin BM, Wei EK, Ng K, Meyerhardt JA, Chan JA, et al. Prediagnostic plasma folate and the risk of death in patients with colorectal cancer. J Clin Oncol. 2008;26(19):3222–3228. doi:10.1200/JCO.2008.16.1943.
   PubMed Web of Science ®Google Scholar
• Tomaszewski JJ, Richman EL, Sadetsky N, O’Keefe DS, Carroll PR, Davies BJ, et al. Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™. J Urol. 2014;191(4):971–976. doi:10.1016/j.juro.2013.09.065.
   PubMed Web of Science ®Google Scholar
• McNulty H, Ward M, Hoey L, Hughes CF, Pentieva K. Addressing optimal folate and related B-vitamin status through the lifecycle: health impacts and challenges. Proc Nutr Soc. 2019;78(3):449–462. doi:10.1017/S0029665119000661.
   PubMed Web of Science ®Google Scholar
• Maktouf C, Bchir A, Louzir H, Mdhaffer M, Elloumi M, Ben Abid H, et al. Megaloblastic anemia in North Africa. Haematologica. 2006;91(7):990–991.
   PubMed Web of Science ®Google Scholar
• Hadj-Taieb S, Feki M, Hammami MB, Omar S, Elasmi M, Kallel A, et al. Plasma total homocysteine: usual values and main determinants in adults living in the Great Tunis region. Clin Lab. 2014;60(6):897–902. doi:10.7754/clin.lab.2013.130723.
   PubMed Web of Science ®Google Scholar
• Miranti EH, Stolzenberg-Solomon R, Weinstein SJ, Selhub J, Männistö S, Taylor PR, et al. Low vitamin B(12) increases risk of gastric cancer: a prospective study of one-carbon metabolism nutrients and risk of upper gastrointestinal tract cancer. Int J Cancer. 2017;141(6):1120–1129. doi:10.1002/ijc.30809.
   PubMed Web of Science ®Google Scholar
• Huang CY, Abulimiti A, Zhang X, Feng XL, Luo H, Chen YM, et al. Dietary B vitamin and methionine intakes and risk for colorectal cancer: a case-control study in China. Br J Nutr. 2020;123(11):1277–1289. doi:10.1017/S0007114520000501.
   PubMed Web of Science ®Google Scholar
• Kim YI. Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr. 2004;80(5):1123–1128. doi:10.1093/ajcn/80.5.1123.
   PubMed Web of Science ®Google Scholar
• Petrova YI, Schecterson L, Gumbiner BM. Roles for E-cadherin cell surface regulation in cancer. Mol Biol Cell. 2016;27(21):3233–3244. doi:10.1091/mbc.E16-01-0058.
   PubMed Web of Science ®Google Scholar
• Petersen LF, Brockton NT, Bakkar A, Liu S, Wen J, Weljie AM, et al. Elevated physiological levels of folic acid can increase in vitro growth and invasiveness of prostate cancer cells. BJU Int. 2012;109(5):788–795. doi:10.1111/j.1464-410X.2011.10437.x.
   PubMed Web of Science ®Google Scholar
• Lindzon GM, Medline A, Sohn KJ, Depeint F, Croxford R, Kim YI. Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci. Carcinogenesis. 2009;30(9):1536–1543. doi:10.1093/carcin/bgp152.
   PubMed Web of Science ®Google Scholar
• Deghan Manshadi S, Ishiguro L, Sohn KJ, Medline A, Renlund R, Croxford R, et al. Folic acid supplementation promotes mammary tumor progression in a rat model. PLoS One. 2014;9(1):e84635. doi:10.1371/journal.pone.0084635.
   PubMed Web of Science ®Google Scholar
• Kotsopoulos J, Sohn KJ, Martin R, Choi M, Renlund R, McKerlie C, et al. Dietary folate deficiency suppresses N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Carcinogenesis. 2003;24(5):937–944. doi:10.1093/carcin/bgg036.
   PubMed Web of Science ®Google Scholar
• Bistulfi G, Foster BA, Karasik E, Gillard B, Miecznikowski J, Dhiman VK, et al. Dietary folate deficiency blocks prostate cancer progression in the TRAMP model. Cancer Prev Res (Phila). 2011;4(11):1825–1834. doi:10.1158/1940-6207.CAPR-11-0140.
   PubMed Web of Science ®Google Scholar
• Ashkavand Z, O’Flanagan C, Hennig M, Du X, Hursting SD, Krupenko SA. Metabolic reprogramming by folate restriction leads to a less aggressive cancer phenotype. Mol Cancer Res. 2017;15(2):189–200. doi:10.1158/1541-7786.MCR-16-0317.
   PubMed Web of Science ®Google Scholar
• Lee YY, Wei YC, Tian YF, Sun DP, Sheu MJ, Yang CC, et al. Overexpression of transcobalamin 1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy. J Cancer. 2017;8(8):1330–1337. doi:10.7150/jca.18274.
   PubMed Web of Science ®Google Scholar
• Liu GJ, Wang YJ, Yue M, Zhao LM, Guo YD, Liu YP, et al. High expression of TCN1 is a negative prognostic biomarker and can predict neoadjuvant chemosensitivity of colon cancer. Sci Rep. 2020;10(1):11951. doi:10.1038/s41598-020-68150-8.
   PubMed Web of Science ®Google Scholar
• Bryan RT, Collins SI, Daykin MC, Zeegers MP, Cheng KK, Wallace DM, et al. Mechanisms of recurrence of Ta/T1 bladder cancer. Ann R Coll Surg Engl. 2010;92(6):519–524. doi:10.1308/003588410X12664192076935.
   PubMed Web of Science ®Google Scholar
• Afonso JP, Freitas R, Lobo F, Morais A, Oliveira J, Amaro T, et al. Urothelial bladder cancer progression: lessons learned from the bench. J Cancer Metastasis Treat. 2015;1(2):57–66. doi:10.4103/2394-4722.157377.
   Google Scholar
• Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 2015;527(7577):186–191. doi:10.1038/nature15726.
   PubMed Web of Science ®Google Scholar